Improving the Mental Health and Well Being of Healthcare Providers Through the Transcendental Meditation Technique

Sponsor
The Center for Clinical and Cosmetic Research (Other)
Overall Status
Completed
CT.gov ID
NCT05239429
Collaborator
David Lynch Foundation (Other)
130
1
2
12
10.8

Study Details

Study Description

Brief Summary

The level of stress-related disorders experienced by Healthcare Providers (HCPs) has increased due to the recent COVID-19 Pandemic, impacting patient care and provider shortages. This trial aims to evaluate the use of the Transcendental Meditation Technique in improving burnout and wellbeing of HCPs over a 3-month trial period.

A total of 130 HCPs will be recruited from participating Miami hospitals, with 65 HCPs receiving training in the use of the Transcendental Meditation Technique. The remaining participants will be part of a matched control group and will not receive any training. Study outcomes will be assessed at baseline, 2 weeks, 1 month, and 3 months.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Transcendental Meditation Technique
N/A

Detailed Description

This parallel population study aims to optimize and evaluate Healthcare Provider (HCP) wellness and performance through an evidence-based stress reduction program, Transcendental Meditation.

Transcendental Meditation (TM) has been found to be effective in reducing adverse mental health outcomes, including burnout, emotional exhaustion, depression, anxiety, insomnia, and trauma symptom severity. It is a mind-body program that allows the practitioner to experience progressively quieter, less excited states of mental activity.

For this trail, 65 HCPs affiliated with three participating Miami hospitals (Baptist Health South Florida Hospital, Mercy Miami Hospital and Encompass Health Rehabilitation Hospital of Miami) will receive instructions in the Transcendental Meditation Technique. A control group of similar numbers of HCPs will be recruited to match, to the best extent possible, for gender, age, type of HCP (doctor, nurse, etc.), and work schedule (e.g., days, nights, etc.). The control group participants will not receive Transcendental Meditation Technique training and will continue with their usual lifestyle.

The total duration of the study period will be 3 months. Study outcomes will be assessed at baseline, 2 weeks, 1 month, and 3 months' posttest, with change in burnout, insomnia, symptom, and well-being, as measured by the corresponding indexes as the primary outcomes.

Study Design

Study Type:
Interventional
Actual Enrollment :
130 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Improving the Mental Health & Well-Being of Healthcare Providers During the COVID-19 Pandemic: A Parallel Population Study Investigating the Reduction of Burnout and Enhancement of Well-Being Through the Transcendental Meditation Technique
Actual Study Start Date :
Jun 30, 2020
Actual Primary Completion Date :
Jun 30, 2021
Actual Study Completion Date :
Jun 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Transcendental Meditation Technique

Participants are trained on the use of the Transcendental Meditation Technique. They will perform the technique twice a day for 20-minutes per session.

Behavioral: Transcendental Meditation Technique
Participants receive one-on-one training on how to use Transcendental Meditation technique which is then practiced twice daily for approximately 20 minutes.

No Intervention: Lifestyle-as-usual (control)

There is no change to the participants daily schedule and lifestyle.

Outcome Measures

Primary Outcome Measures

  1. Change in Maslach Burnout Inventory- Human Services Survey (MBI-HSS) Score from Baseline [Baseline, 2 weeks, 1 month, and 3 months]

    The Maslach Burnout Inventory- Human Services Survey (MBI-HSS) for Medical Personnel is used to measure participant burnout. The scale is a 22-item inventory with a seven-point response scale of 0-6 (0=never; 6= Every day).

  2. Change from Baseline in Insomnia Severity Index (ISI) Score [Baseline, 2 weeks, 1 month, and 3 months]

    The Insomnia Severity Index (ISI) scale contains 7 sleep-related questions to measure severity of sleep problems. A total score is calculated to interpret the participants level of insomnia, with a total score of 0-7 indicating no clinically significant insomnia and a score of 22-18 indicative of severe Clinical Insomnia.

  3. Change from Baseline in Brief Symptom Inventory 18 (BSI 18) Score [Baseline, 2 weeks, 1 month, and 3 months]

    The Brief Symptom Inventory 18 (BSI 18) is a 5-point rating scale used to gather patient-reported data to measure psychological distress and psychiatric disorders.

  4. Change in Warwick-Edinburgh Mental Well Being Scale (WEMWBS) Score from Baseline [Baseline, 2 weeks, 1 month, and 3 months]

    The Warwick-Edinburgh Mental Well Being Scale (WEMWBS) scale, covering both feeling and functioning aspects of mental wellbeing, contains 14 -items with 5 response categories, summed to provide a total score.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Fulltime healthcare providers, medical doctors, physician assistants, nurses or other HCPs involved in active patient care or administration of patient care (Hospital Administration).

  2. 18 years or older.

  3. Have treated COVID-19 patients or working at locations where COVID-19 patients are being treated.

  4. Willing and able to complete both baseline and post-testing.

  5. If being treated with psychoactive medications, the maintenance of a stable regimen for at least two months before enrollment.

  6. In the non-control group, willing and able to dedicate the time to learning the Transcendental Meditation technique and practice it twice daily for approximately 20 minutes.

Exclusion Criteria:
  1. Already instructed in the Transcendental Meditation technique.

  2. Currently unstable psychiatric symptoms as demonstrated by self-report, medical chart, or psychiatric hospitalizations in the past six months.

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Center for Clinical and Cosmetic Research Aventura Florida United States 33180

Sponsors and Collaborators

  • The Center for Clinical and Cosmetic Research
  • David Lynch Foundation

Investigators

  • Principal Investigator: Mark S Nestor, M.D., Ph.D., Center for Clinical and Cosmetic Research

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Mark Steven Nestor, M.D., Ph.D., Director, The Center for Clinical and Cosmetic Research
ClinicalTrials.gov Identifier:
NCT05239429
Other Study ID Numbers:
  • CCCR 01-2020
First Posted:
Feb 14, 2022
Last Update Posted:
Feb 15, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mark Steven Nestor, M.D., Ph.D., Director, The Center for Clinical and Cosmetic Research
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 15, 2022